NASDAQ:TRHC

Tabula Rasa HealthCare Competitors

$43.16
+0.06 (+0.14 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$42.15
Now: $43.16
$43.49
50-Day Range
$34.50
MA: $43.36
$48.60
52-Week Range
$30.12
Now: $43.16
$69.31
Volume136,100 shs
Average Volume452,642 shs
Market Capitalization$1.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.05

Competitors

Tabula Rasa HealthCare (NASDAQ:TRHC) Vs. MPLN, AMWL, ENV, STMP, WNS, and HMSY

Should you be buying TRHC stock or one of its competitors? Companies in the industry of "business services, not elsewhere classified" are considered alternatives and competitors to Tabula Rasa HealthCare, including MultiPlan (MPLN), American Well (AMWL), Envestnet (ENV), Stamps.com (STMP), WNS (WNS), and HMS (HMSY).

Tabula Rasa HealthCare (NASDAQ:TRHC) and MultiPlan (NYSE:MPLN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and MultiPlan's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tabula Rasa HealthCare$284.71 million3.74$-32,440,000.00($0.25)-172.64
MultiPlanN/AN/AN/AN/AN/A

MultiPlan has lower revenue, but higher earnings than Tabula Rasa HealthCare.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and MultiPlan, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tabula Rasa HealthCare06302.33
MultiPlan01302.75

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. MultiPlan has a consensus target price of $9.25, suggesting a potential upside of 48.00%. Given MultiPlan's stronger consensus rating and higher probable upside, analysts clearly believe MultiPlan is more favorable than Tabula Rasa HealthCare.

Insider and Institutional Ownership

0.1% of MultiPlan shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and MultiPlan's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tabula Rasa HealthCare-19.48%-11.53%-4.22%
MultiPlanN/AN/AN/A

Summary

MultiPlan beats Tabula Rasa HealthCare on 6 of the 8 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and American Well (NYSE:AMWL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and American Well's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tabula Rasa HealthCare$284.71 million3.74$-32,440,000.00($0.25)-172.64
American WellN/AN/AN/AN/AN/A

American Well has lower revenue, but higher earnings than Tabula Rasa HealthCare.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and American Well, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tabula Rasa HealthCare06302.33
American Well06402.40

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. American Well has a consensus target price of $33.25, suggesting a potential upside of 93.99%. Given American Well's stronger consensus rating and higher probable upside, analysts clearly believe American Well is more favorable than Tabula Rasa HealthCare.

Insider and Institutional Ownership

19.0% of American Well shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and American Well's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tabula Rasa HealthCare-19.48%-11.53%-4.22%
American WellN/AN/AN/A

Summary

American Well beats Tabula Rasa HealthCare on 7 of the 9 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and Envestnet (NYSE:ENV) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and Envestnet's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tabula Rasa HealthCare$284.71 million3.74$-32,440,000.00($0.25)-172.64
Envestnet$900.13 million4.49$-16,780,000.00$1.2161.74

Envestnet has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Envestnet, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and Envestnet, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tabula Rasa HealthCare06302.33
Envestnet03712.82

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. Envestnet has a consensus target price of $87.20, suggesting a potential upside of 16.73%. Given Tabula Rasa HealthCare's higher probable upside, research analysts clearly believe Tabula Rasa HealthCare is more favorable than Envestnet.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, Envestnet has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500.

Profitability

This table compares Tabula Rasa HealthCare and Envestnet's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tabula Rasa HealthCare-19.48%-11.53%-4.22%
Envestnet-0.69%10.44%4.91%

Summary

Envestnet beats Tabula Rasa HealthCare on 11 of the 13 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and Stamps.com (NASDAQ:STMP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and Stamps.com's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tabula Rasa HealthCare$284.71 million3.74$-32,440,000.00($0.25)-172.64
Stamps.com$571.85 million6.61$59.23 million$3.3361.75

Stamps.com has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Stamps.com, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and Stamps.com, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tabula Rasa HealthCare06302.33
Stamps.com01102.50

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. Stamps.com has a consensus target price of $260.00, suggesting a potential upside of 26.43%. Given Stamps.com's stronger consensus rating and higher probable upside, analysts clearly believe Stamps.com is more favorable than Tabula Rasa HealthCare.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Stamps.com has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500.

Insider and Institutional Ownership

88.2% of Stamps.com shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Comparatively, 9.6% of Stamps.com shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and Stamps.com's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tabula Rasa HealthCare-19.48%-11.53%-4.22%
Stamps.com21.40%21.50%16.08%

Summary

Stamps.com beats Tabula Rasa HealthCare on 11 of the 14 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and WNS (NYSE:WNS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and WNS's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tabula Rasa HealthCare$284.71 million3.74$-32,440,000.00($0.25)-172.64
WNS$928.30 million3.88$116.77 million$2.5428.50

WNS has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than WNS, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and WNS, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tabula Rasa HealthCare06302.33
WNS02802.80

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. WNS has a consensus target price of $76.30, suggesting a potential upside of 5.39%. Given Tabula Rasa HealthCare's higher probable upside, research analysts clearly believe Tabula Rasa HealthCare is more favorable than WNS.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, WNS has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500.

Insider and Institutional Ownership

99.7% of WNS shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and WNS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tabula Rasa HealthCare-19.48%-11.53%-4.22%
WNS11.37%19.39%11.66%

Summary

WNS beats Tabula Rasa HealthCare on 12 of the 14 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and HMS (NASDAQ:HMSY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and HMS's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tabula Rasa HealthCare$284.71 million3.74$-32,440,000.00($0.25)-172.64
HMS$626.40 million5.23$87.22 million$1.1532.15

HMS has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than HMS, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and HMS, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tabula Rasa HealthCare06302.33
HMS012102.08

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. HMS has a consensus target price of $34.25, suggesting a potential downside of 7.37%. Given Tabula Rasa HealthCare's stronger consensus rating and higher probable upside, research analysts clearly believe Tabula Rasa HealthCare is more favorable than HMS.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, HMS has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.

Insider and Institutional Ownership

95.8% of HMS shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Comparatively, 2.7% of HMS shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and HMS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tabula Rasa HealthCare-19.48%-11.53%-4.22%
HMS8.51%8.86%6.18%

Summary

HMS beats Tabula Rasa HealthCare on 9 of the 14 factors compared between the two stocks.


Tabula Rasa HealthCare Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
MPLN
MultiPlan
1.2$6.25+0.3%$4.18 billionN/A0.00Analyst Report
Analyst Revision
American Well logo
AMWL
American Well
1.4$17.14+1.6%$4.08 billionN/A0.00Insider Selling
Envestnet logo
ENV
Envestnet
1.2$74.70+0.5%$4.04 billion$900.13 million-574.62Analyst Report
Analyst Revision
News Coverage
Stamps.com logo
STMP
Stamps.com
1.7$205.64+0.5%$3.78 billion$571.85 million25.48
WNS logo
WNS
WNS
1.8$72.40+0.5%$3.60 billion$928.30 million35.84
HMS logo
HMSY
HMS
1.4$36.98+0.0%$3.28 billion$626.40 million60.61
ExlService logo
EXLS
ExlService
1.3$92.81+0.6%$3.11 billion$991.35 million40.89
Accolade logo
ACCD
Accolade
1.5$47.18+0.8%$2.62 billionN/A0.00Analyst Report
Phreesia logo
PHR
Phreesia
1.6$52.88+0.6%$2.37 billion$124.78 million-88.13
EVO Payments logo
EVOP
EVO Payments
1.4$28.37+0.2%$2.35 billion$485.78 million-105.07
NIC logo
EGOV
NIC
1.6$33.98+0.1%$2.28 billion$354.20 million37.76
Repay logo
RPAY
Repay
1.5$24.22+1.1%$2.13 billion$104.60 million-71.23Insider Selling
TechTarget logo
TTGT
TechTarget
1.5$72.58+2.2%$2.04 billion$133.96 million115.21Analyst Report
CBIZ logo
CBZ
CBIZ
1.3$33.62+0.9%$1.80 billion$948.42 million24.19
Cardtronics logo
CATM
Cardtronics
1.1$38.82+0.1%$1.75 billion$1.35 billion77.64
B. Riley Financial logo
RILY
B. Riley Financial
1.1$61.41+2.3%$1.67 billion$652.11 million38.87
Conduent logo
CNDT
Conduent
1.1$6.73+1.0%$1.43 billion$4.47 billion-2.05
Radware logo
RDWR
Radware
1.7$26.71+0.4%$1.25 billion$252.07 million92.10
GreenSky logo
GSKY
GreenSky
1.3$6.20+1.5%$1.13 billion$529.65 million124.02
QuinStreet logo
QNST
QuinStreet
2.0$20.16+0.7%$1.07 billion$490.34 million34.17
i3 Verticals logo
IIIV
i3 Verticals
1.7$32.47+1.1%$1.04 billion$150.13 million-811.75Analyst Upgrade
Gravity logo
GRVY
Gravity
0.7$127.88+4.6%$888.64 million$307.18 million22.05
Viad logo
VVI
Viad
1.1$41.18+0.5%$843.28 million$1.37 billion-4.33
OptimizeRx logo
OPRX
OptimizeRx
1.5$49.35+0.7%$829.43 million$24.60 million-129.87
Advantage Solutions logo
ADV
Advantage Solutions
1.7$12.89+0.4%$728.29 millionN/A0.00News Coverage
Ideanomics logo
IDEX
Ideanomics
0.5$2.95+3.7%$704.96 million$44.57 million-2.50
Rimini Street logo
RMNI
Rimini Street
1.7$9.03+1.1%$694.50 million$281.05 million-34.73
Qiwi logo
QIWI
Qiwi
1.7$10.64+0.9%$667.27 million$635.40 million6.95
Liquidity Services logo
LQDT
Liquidity Services
1.3$18.87+1.0%$659.00 million$205.94 million-171.55Analyst Downgrade
Cass Information Systems logo
CASS
Cass Information Systems
0.9$45.64+0.5%$657.08 million$157.24 million26.53
Newtek Business Services logo
NEWT
Newtek Business Services
1.4$27.55+0.0%$617.12 million$59.29 million18.49Analyst Downgrade
International Money Express logo
IMXI
International Money Express
2.0$14.97+1.6%$572.12 million$319.60 million19.19Analyst Upgrade
MoneyGram International logo
MGI
MoneyGram International
1.4$6.49+2.5%$503.48 million$1.29 billion-17.08
Priority Technology logo
PRTH
Priority Technology
1.7$7.10+0.8%$480.23 million$371.85 million25.36
RGP
Resources Connection
1.7$14.29+1.9%$464.54 million$703.35 million37.61Earnings Announcement
News Coverage
Limelight Networks logo
LLNW
Limelight Networks
1.8$3.58+0.8%$444.40 million$200.63 million-59.67
UXIN
Uxin
0.5$1.40+2.9%$414.25 million$227.64 million-0.81
Digital Media Solutions logo
DMS
Digital Media Solutions
1.3$12.28+0.9%$397.79 millionN/A0.00Analyst Report
Emerald logo
EEX
Emerald
0.7$5.49+4.4%$396.78 million$360.90 million-0.60
Waitr logo
WTRH
Waitr
1.6$2.81+0.7%$313.38 million$191.68 million-0.91
QH
Quhuo
0.7$6.01+0.2%$311.70 million$295.30 million0.00
comScore logo
SCOR
comScore
2.0$3.47+1.2%$262.98 million$388.64 million-4.28
Points International logo
PCOM
Points International
1.1$16.00+1.1%$238.64 million$401.18 million-99.99
PaySign logo
PAYS
PaySign
1.1$4.14+1.7%$208.85 million$34.67 million-69.00
MOGU logo
MOGU
MOGU
1.8$1.97+3.6%$189.79 million$117.97 million-0.76
DHI Group logo
DHX
DHI Group
2.1$2.95+5.8%$154.39 million$149.37 million-5.00Analyst Upgrade
News Coverage
PFSweb logo
PFSW
PFSweb
1.4$7.07+1.3%$144.12 million$294.02 million-58.91
ServiceSource International logo
SREV
ServiceSource International
1.8$1.41+1.4%$137.20 million$216.13 million-6.71News Coverage
Exela Technologies logo
XELA
Exela Technologies
0.8$2.17+4.1%$127.96 million$1.56 billion-0.64
36Kr logo
KRKR
36Kr
1.3$3.39+0.0%$127.11 million$94.17 million-6.05News Coverage
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.